CELLULAR ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

引言中如何全面包含本领域重要研究？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

引言一般引用多少篇参考文献？

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2012-11-18 匿名用户

审稿速度:12.0 | 投稿命中率:25.0
经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。

346 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2019-09-14 121c6f2dm84(暂无昵称)

3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表:
请问下平均审稿时间是多少？

上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？

179 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2019-12-31 146d7912m38暂无昵称

你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表::
请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表:
请问这个期刊还是SCI吗？为什么在小木虫里面显示“
CELLULAR ONCOLOGY
根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”

青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”

123 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2023-08-13 ms1000001604956933 来自四川省

偏重的研究方向：肿瘤;综述
经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。

39 0

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2023-06-26 ms4000000100225658 来自上海

最近有人投吗？我的半年了还在underreview

37 0

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-10-26 ms9000001266376727

审稿速度:6.0 | 投稿命中率:25.0
经验分享：无

58 0

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2022-07-27 柏文

审稿很快，很负责任的主编

45 0

[GetPortalCommentsPageByObjectIdResponse(id=1088508, encodeId=be1a108850898, content=引言中如何全面包含本领域重要研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088507, encodeId=7d72108850e19, content=引言一般引用多少篇参考文献？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491509, encodeId=040a49150975, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：一篇文章外审5个月后一个审稿人评价不高，一个还可以，建议大修。大修了6个月，投稿2周直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 18 15:39:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576286, encodeId=6c6a5e628633, content=3-4个月还是要的上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, beContent=上天擒佛祖 2019-01-31 00:00:00 发表: 请问下平均审稿时间是多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Sat Sep 14 00:00:00 CST 2019, time=2019-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582450, encodeId=b7a658245086, content=你查查wos吧，整天查小木虫，里面的数据都不知道多少年前的了青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”青青青青 2019-08-07 12:50:00 发表: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, beContent=青青青青 2019-08-07 发表:: 请问这个期刊还是SCI吗？为什么在小木虫里面显示“ CELLULAR ONCOLOGY 根据目前最新的SCI数据，此期刊已经不再属于 SCI 期刊系列”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e90d5170839, createdName=146d7912m38暂无昵称, createdTime=Tue Dec 31 00:00:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152556, encodeId=4ee12152556a8, content=偏重的研究方向：肿瘤;综述 经验分享：上一个杂志被拒稿后出版社推荐了这个杂志。查了一下今年年初刚接受了一篇另一癌肿和我们很像的综述。结果秒拒也没有给任何理由。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad18334709, createdName=ms1000001604956933, createdTime=Sun Aug 13 12:48:17 CST 2023, time=2023-08-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2144836, encodeId=795a2144836d6, content=最近有人投吗？我的半年了还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fc18267860, createdName=ms4000000100225658, createdTime=Mon Jun 26 17:39:42 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2096233, encodeId=148520962331c, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c48396958, createdName=ms9000001266376727, createdTime=Wed Oct 26 10:38:16 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235083, encodeId=dd771235083d2, content=审稿很快，很负责任的主编, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqWqPkWSGh3aEwcOXibv887XUhKFMqVHRib7QhuJXzYI10TdB3vIVI16Vh50OdBtWOdCWHOrW7G6p7A/132, createdBy=60462068466, createdName=柏文, createdTime=Wed Jul 27 16:16:30 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977458, encodeId=f8059e74583b, content=偏重的研究方向：肿瘤;胰腺癌 经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210502/30b76b41753446b5926067b0863431ca/9447fc5195004627a013761db81a196a.png, createdBy=1b9f2459140, createdName=12413506m06(暂无昵称), createdTime=Mon Jun 28 00:17:38 CST 2021, time=2021-06-28, status=1, ipAttribution=)]

2021-06-28 12413506m06(暂无昵称)

偏重的研究方向：肿瘤;胰腺癌
经验分享：超级超级超级超级慢，投稿过去一个多月，一直是editor invited，中间发过两次询问邮件，完全不理会，没有回复的。最后实在等不了，发了撤稿邮件，tnnd撤稿邮件两天就处理了

80 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务